Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether guanfacine (trade name Intuniv) by itself
or in combination with methylphenidate (also known as Ritalin) is helpful for treating
hyperactivity in children and adolescents with a Pervasive Developmental Disorders (PDDs).
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborators:
Emory University Massachusetts General Hospital National Institute of Mental Health (NIMH) Seattle Children's Hospital University of California, Los Angeles